Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

695
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
695
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

363
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
363
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

231
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
231
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

233
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
233
Exponential Functions with Base e01:30

Exponential Functions with Base e

261
Exponential functions with base e are essential for modeling continuous processes of growth and decay. The constant e, approximately 2.718, naturally arises in systems where change occurs proportionally to the current value. A positive exponent represents continuous growth, while a negative exponent represents continuous decay. These functions are especially useful for describing situations where change happens smoothly over time rather than in discrete steps.One clear example of exponential...
261
Exponential and Sinusoidal Signals01:18

Exponential and Sinusoidal Signals

741
The exponential function is crucial for characterizing waveforms that rise and decay rapidly. This continuous-time exponential function is defined using exponential terms with constants α and A. When both constants are real, the function is represented as,
741

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies.

Seminars in nuclear medicine·2026
Same author

Targeting Fibroblast Activation Protein with [177Lu]Lu-FAP-2286 in Patients with Advanced Solid Tumors in the Phase I LuMIERE Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A Phase 0 Imaging Trial of [<sup>203</sup>Pb]Pb-VMT-α-NET to Enable Dosimetry and Treatment Planning for Refractory or Relapsed Metastatic Neuroendocrine Tumors with [<sup>212</sup>Pb]Pb-VMT-α-NET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Enhancing PRRT Outcome Prediction in Neuroendocrine Tumors: Aggregated Multi-Lesion PET Radiomics Incorporating Inter-Tumor Heterogeneity.

Cancers·2025
Same author

Posttreatment SPECT/CT as a Prognostic Tool in Patients Treated with <sup>177</sup>Lu-PSMA-617.

Radiology. Imaging cancer·2025
Same journal

Correction to "On the shape of the radiation survival curve in tumor spheroids: The role of oxygen heterogeneity".

Medical physics·2026
Same journal

Multi-view constrained semi-supervised vertebra detection for 3D ultrasound spine volume.

Medical physics·2026
Same journal

Accuracy of quantitative <sup>177</sup>Lu SPECT/CT imaging: A systematic review.

Medical physics·2026
Same journal

Physics-constrained dual-domain network for CBCT reconstruction from orthogonal X-rays in gynecologic radiotherapy.

Medical physics·2026
Same journal

Decomposition-based harmonization for quantitative PET imaging across scanners and radiotracers.

Medical physics·2026
Same journal

Development and evaluation of an in vivo dose-based monitoring system for electron FLASH radiation therapy.

Medical physics·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents
09:42

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents

Published on: August 7, 2013

10.9K

Technical Note: Single time point dose estimate for exponential clearance.

Mark T Madsen1, Yusuf Menda1, Thomas M O'Dorisio2

  • 1Department of Radiology, University of Iowa, Iowa City, IA, 52242, USA.

Medical Physics
|March 27, 2018
PubMed
Summary
This summary is machine-generated.

Estimating total integrated activity and radiation dose from a single time sample in radionuclide therapy is feasible. This approach simplifies personalized dosimetry by leveraging prior knowledge of tracer kinetic parameters.

Keywords:
exponential clearancepersonalized radionuclide therapyradiation dose estimatesingle sample time

More Related Videos

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.6K
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
09:59

A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia

Published on: September 16, 2017

14.6K

Related Experiment Videos

Last Updated: Feb 12, 2026

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents
09:42

Deriving the Time Course of Glutamate Clearance with a Deconvolution Analysis of Astrocytic Transporter Currents

Published on: August 7, 2013

10.9K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.6K
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
09:59

A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia

Published on: September 16, 2017

14.6K

Area of Science:

  • Nuclear medicine
  • Medical physics
  • Radiopharmaceutical dosimetry

Background:

  • Personalized dosimetry in radionuclide therapy is crucial but resource-intensive.
  • Current methods require multiple patient time samples, increasing burden.

Purpose of the Study:

  • To demonstrate the feasibility of estimating total integrated activity from a single time sample.
  • To simplify personalized dosimetry in radionuclide therapy.

Main Methods:

  • Mathematical derivation of equations for single-time-point activity estimation.
  • Simulations using monoexponential and biexponential clearance models.
  • Retrospective analysis of 90Y DOTATOC clinical trial data.

Main Results:

  • Optimal sampling time identified as the mean time of the rate constant.
  • High correlations (r² > 0.95) between actual and estimated total integrated activity.
  • Clinical data confirmed accuracy with r² = 0.95.

Conclusions:

  • Single time point approach is accurate for estimating total integrated activity and dose.
  • Prior knowledge of population kinetic parameters enables simplified personalized dosimetry.
  • This method enhances the accessibility and ease of personalized dosimetry.